Completed PHASE4 INTERVENTIONAL 3-arm NCT01951001

Fixed-dose vs. Phenotype-based PrAsugrel Dose to MATCH Therapeutic Zone in Asians With Acute Coronary Syndrome

Sponsor: Gyeongsang National University Hospital

Conditions Acute Coronary Syndrome Bleeding Platelet Thrombus

Interventions Prasugrel

Updated 7 times since 2017 Last updated: Aug 18, 2020 Started: Jul 31, 2013 Primary completion: Jun 30, 2015 Completion: Oct 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01951001, this PHASE4 trial focuses on Acute Coronary Syndrome and Bleeding and remains completed. Sponsored by Gyeongsang National University Hospital, it has been updated 7 times since 2013, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Sep 2020 — Jan 2021 [monthly]

Completed PHASE4

Status: Unknown Status → Completed

▶ Show 2 earlier versions

Jun 2018 — Sep 2020 [monthly]

Unknown Status PHASE4
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Jul 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Gyeongsang National University Hospital

Data source: Gyeongsang National University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jinju, South Korea